Study guide

3.3 Hematologic Malignancies & Lymphoproliferative Disorders

USMLE Step 2 CK Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Human Development & Well-Patient Care

1.1 Infant, Child & Adolescent Development & Growth 1.2 Adult Development, Aging & Geriatric Assessment 1.3 Preventive Health, Immunization & Well-Patient Screening

2 Chapter 2: Immune System & Immunologic Disorders

2.1 Primary & Secondary Immunodeficiencies 2.2 Hypersensitivity Reactions, Allergy & Anaphylaxis 2.3 Autoimmune & Rheumatologic Disease Principles

3 Chapter 3: Blood & Lymphoreticular System

3.1 Anemias: Microcytic, Normocytic & Macrocytic Etiologies 3.2 Bleeding Disorders, Coagulopathies & Platelet Pathology 3.3 Hematologic Malignancies & Lymphoproliferative Disorders

4 Chapter 4: Behavioral Health & Psychiatric Disorders

4.1 Mood Disorders: Major Depression & Bipolar Spectrum 4.2 Anxiety, Trauma-Related & Somatic Symptom Disorders 4.3 Psychotic Disorders & Schizophrenia Spectrum 4.4 Substance Use Disorders & Psychopharmacology

5 Chapter 5: Nervous System & Special Senses

5.1 Cerebrovascular Disease, Stroke & Transients 5.2 Seizures, Epilepsy & Altered Mental Status 5.3 Movement Disorders, Dementia & Peripheral Neuropathies 5.4 Special Senses: Ophthalmologic & Otolaryngologic Emergencies

6 Chapter 6: Musculoskeletal System & Dermatology

6.1 Fractures, Dislocations & Orthopedic Trauma 6.2 Inflammatory Arthropathies & Crystal-Induced Diseases 6.3 Inflammatory & Infectious Dermatoses 6.4 Cutaneous Malignancies & Blistering Disorders

7 Chapter 7: Cardiovascular System

7.1 Coronary Artery Disease & Acute Coronary Syndromes 7.2 Heart Failure, Cardiomyopathies & Valvular Disease 7.3 Cardiac Arrhythmias, Conduction Blocks & EKG Interpretation 7.4 Vascular Emergencies: Aortic Aneurysms & Peripheral Arterial Disease

8 Chapter 8: Respiratory System

8.1 Obstructive Airway Diseases: Asthma & COPD 8.2 Infectious Pneumonias & Pleural Effusions 8.3 Pulmonary Vascular Disease & Thromboembolism 8.4 Acute Respiratory Distress Syndrome & Interstitial Lung Diseases

9 Chapter 9: Gastrointestinal System

9.1 Esophageal, Gastric & Peptic Ulcer Disorders 9.2 Inflammatory Bowel Disease & Colorectal Neoplasms 9.3 Hepatic Disorders, Cirrhosis & Portal Hypertension 9.4 Biliary Tract Diseases & Pancreatitis

10 Chapter 10: Renal, Urinary & Reproductive Systems

10.1 Acute Kidney Injury & Chronic Kidney Disease 10.2 Glomerular & Tubulointerstitial Diseases 10.3 Nephrolithiasis, Urinary Tract Infections & Prostate Pathology 10.4 Fluid, Electrolyte & Acid-Base Disorders 10.5 Female Reproductive Disorders & Gynecology 10.6 Breast Pathology & Clinical Breast Disease

11 Chapter 11: Pregnancy, Childbirth & Puerperium

11.1 Normal Prenatal Care & Maternal-Fetal Physiology 11.2 Medical & Obstetric Complications of Pregnancy 11.3 Labor, Delivery & Postpartum Management

12 Chapter 12: Endocrine System

12.1 Diabetes Mellitus, Hypoglycemia & Metabolic Emergencies 12.2 Thyroid & Parathyroid Disorders 12.3 Adrenal & Pituitary Axis Pathology

13 Chapter 13: Multisystem Processes & Critical Care

13.1 Shock States, Sepsis & Systemic Inflammatory Response 13.2 Environmental Emergencies, Toxicology & Overdose 13.3 Infectious Disease Principles & Systemic Pathogens

14 Chapter 14: Biostatistics, Epidemiology & Literature Interpretation

14.1 Study Designs, Bias & Validity 14.2 Diagnostic Testing: Sensitivity, Specificity, PPV & NPV 14.3 Statistical Significance, Risk Measures & Evidence-Based Medicine

15 Chapter 15: Social Sciences, Ethics & Systems-Based Practice

15.1 Medical Ethics, Informed Consent & Patient Autonomy 15.2 Legal Issues, Confidentiality & Surrogate Decision Making 15.3 Patient Safety, Quality Improvement & Medical Error Analysis 15.4 Health Care Delivery Systems, Interprofessional Care & Transitions

3.3 Hematologic Malignancies & Lymphoproliferative Disorders

Key Takeaways Explain This Topic AI

Acute Leukemias (AML and ALL) are defined by ≥ 20% blasts in the bone marrow or peripheral blood; Acute Promyelocytic Leukemia (APL, AML M3) with t(15;17) PML-RARA translocation carries high risk of fatal DIC and requires immediate All-trans retinoic acid (ATRA) plus arsenic trioxide.

Chronic Myelogenous Leukemia (CML) is driven by the t(9;22) Philadelphia chromosome creating the BCR-ABL1 fusion tyrosine kinase, presenting with extreme leukocytosis, basophilia, low leukocyte alkaline phosphatase (LAP) score, and dramatic response to imatinib.

Multiple Myeloma is diagnosed by bone marrow clonal plasma cells ≥ 10% (or biopsy-proven plasmacytoma) plus CRAB end-organ damage: Hypercalcemia (> 11 mg/dL), Renal insufficiency (Cr > 2.0 mg/dL), Anemia (Hgb < 10 g/dL), and Lytic bone lesions.

Hodgkin Lymphoma is characterized by Reed-Sternberg cells (binucleated "owl-eye" CD15+ CD30+ B-cells) presenting with painless lymphadenopathy and B symptoms (fever, night sweats, weight loss > 10%), demonstrating a bimodal age distribution (ages 20-30 and > 55).

Chronic Lymphocytic Leukemia (CLL) is the most common adult leukemia in Western countries, characterized by absolute lymphocytosis (> 5,000/µL) of mature CD5+ CD19+ B-cells, peripheral smear smudge cells, and potential transformation into diffuse large B-cell lymphoma (Richter transformation).

Last updated: July 2026

Diagnostic Classification of Hematologic Malignancies

Hematologic malignancies on USMLE Step 2 CK are divided into acute leukemias (rapid proliferation of immature blast cells ≥ 20%), chronic myeloproliferative/lymphoproliferative neoplasms (indolent proliferation of mature blood cells), lymphomas (solid tumors of lymphoid tissue), and plasma cell dyscrasias (monoclonal immunoglobulins).

Acute Leukemias: AML vs. ALL

Acute leukemias present with signs of bone marrow failure: anemia (fatigue), thrombocytopenia (petechiae, bleeding), and neutropenia (recurrent infections).

Acute Myeloid Leukemia (AML)

Defined by ≥ 20% myeloblasts in bone marrow or peripheral blood. Blasts stain positive for myeloperoxidase (MPO) and contain crystalline rod-like cytoplasmic inclusions called Auer rods .

Acute Promyelocytic Leukemia (APL / AML M3 Subtype) : Caused by t(15;17) translocation, forming the PML-RARA fusion gene. Translocation disrupts retinoic acid receptor alpha, arresting promyelocyte differentiation. Promyelocytes release tissue factor, causing severe, often fatal Disseminated Intravascular Coagulation (DIC) .

APL Management : Emergency administration of All-Trans Retinoic Acid (ATRA) combined with arsenic trioxide , which induces differentiation of promyelocytes into mature granulocytes, rapidly reversing DIC risk.

Acute Lymphoblastic Leukemia (ALL)

Predominantly a pediatric disease (peak age 2–5 years). Defined by ≥ 20% lymphoblasts staining positive for Terminal Deoxynucleotidyl Transferase (TDT) and B-cell markers ( CD10 [CALLA] , CD19, CD20) or T-cell markers (CD2, CD3, CD7).

T-cell ALL : Classic presentation in adolescent males with a large anterior mediastinal mass (causing superior vena cava syndrome or dyspnea).

Management : Multi-agent chemotherapy including mandatory CNS prophylaxis (intrathecal methotrexate) and testicular surveillance to eradicate occult sanctuaries.

Chronic Myeloproliferative & Lymphoproliferative Neoplasms

Disease Primary Lineage Key Cytogenetic / Molecular Finding Pathognomonic Features

CML Granulocytes (Neutrophils, Basophils) t(9;22) BCR-ABL1 (Philadelphia Chromosome) Low LAP score; Basophilia; Treated with Imatinib

Polycythemia Vera Erythrocytes JAK2 V617F mutation (> 95%) Low EPO; Aquagenic pruritus; Erythromelalgia

Essential Thrombocythemia Megakaryocytes JAK2 V617F , CALR, or MPL mutation Platelets > 450,000/µL; Digital ischemia

Primary Myelofibrosis Fibroblasts (reactive to megakaryocytes) JAK2 V617F mutation (~50%) Teardrop RBCs (dacrocytes); Massive splenomegaly

  • CLL / SLL Mature B-cells Trisomy 12, 17p deletion Smudge cells; CD5+ CD19+; AIHA risk
  • Hairy Cell Leukemia Mature B-cells BRAF V600E mutation TRAP positive; Dry marrow tap; Cladribine therapy
  • Chronic Myelogenous Leukemia (CML)

Driven by reciprocal translocation t(9;22)(q34;q11) , placing the ABL1 tyrosine kinase gene on chromosome 22 ( BCR ), creating the constitutively active BCR-ABL1 fusion protein . Presents with extreme leukocytosis (> 100,000/µL), full spectrum of granulocyte precursors (myelocytes, metamyelocytes), and prominent basophilia .

Differentiating CML from Leukemoid Reaction : CML demonstrates a low Leukocyte Alkaline Phosphatase (LAP) score , whereas a leukemoid reaction (severe infection) demonstrates an elevated LAP score .

Treatment : Imatinib , a small-molecule tyrosine kinase inhibitor targeting BCR-ABL1.

Chronic Lymphocytic Leukemia (CLL)

Most common leukemia in adults in Western countries (median age 70). Characterized by proliferation of incompetent mature B-cells ( CD5+ , CD19+, CD23+). Peripheral smear reveals fragile lymphocytes that disrupt during slide preparation, forming smudge cells (gumdrop cells).

Complications : Immune dysfunction leading to hypogammaglobulinemia (recurrent bacterial infections) and Autoimmune Hemolytic Anemia (AIHA) .

Richter Transformation : Sudden transformation of indolent CLL into aggressive Diffuse Large B-Cell Lymphoma (DLBCL) , marked by rapidly enlarging isolated lymph node and B symptoms.

  • Lymphomas: Hodgkin vs. Non-Hodgkin [ Patient with Painless Lymphadenopathy ]
  • │
  • Excisional Lymph Node Biopsy
  • │
  • ┌───────────┴───────────┐
  • ▼ ▼
  • Reed-Sternberg Cells No Reed-Sternberg Cells
  • (CD15+, CD30+ B-cells) (Non-Hodgkin Lymphoma)
  • │ │
  • Hodgkin Lymphoma Flow Cytometry & Cytogenetics
  • ┌──────┴──────┐ ┌──────┼──────┬──────┐
  • ▼ ▼ ▼ ▼ ▼ ▼
  • Nodular Mixed DLBCL Follicular Burkitt Mantle
  • Sclerosis Cellularity (BCL6) t(14;18) t(8;14) t(11;14)
  • (Young women (Elderly / BCL2 MYC Cyclin D1
  • Mediastinal EBV+)
  • mass)
  • Hodgkin Lymphoma (HL)

Characterized by Reed-Sternberg (RS) cells : giant binucleated B-cells with prominent inclusion-like nucleoli ("owl-eye appearance"), immunophenotypically CD15+ and CD30+ . Bimodal age distribution (ages 20–30 and > 55). Presents with painless cervical lymphadenopathy and systemic B symptoms (fever > 38°C, drenching night sweats, weight loss > 10% over 6 months).

Nodular Sclerosis : Most common subtype (65–70%), especially in young females. Biopsy demonstrates fibrous collagen bands circumscribing nodular aggregates; frequently presents with a mediastinal mass .

Non-Hodgkin Lymphoma (NHL)

Diffuse Large B-Cell Lymphoma (DLBCL) : Most common high-grade NHL in adults. Aggressive, rapidly enlarging nodal mass. Stains positive for BCL6 and CD20. Treated with R-CHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone).

Follicular Lymphoma : Indolent B-cell lymphoma caused by t(14;18) translocation, overexpressing BCL2 (anti-apoptotic protein). Presents with painless, waxing-and-waning lymphadenopathy.

Burkitt Lymphoma : Highly aggressive B-cell tumor caused by t(8;14) translocation overexpressing c-MYC (transcription activator). Histology shows "starry sky" appearance (macrophages ingesting apoptotic tumor cells against a dark background of lymphocytes). Strongly linked to EBV (endemic jaw tumor in Africa; sporadic abdominal/ileocecal mass in US).

  • Plasma Cell Dyscrasias
  • Multiple Myeloma

Neoplastic proliferation of monoclonal plasma cells in bone marrow producing excess monoclonal immunoglobulin ( M-spike on SPEP/UPEP, usually IgG or IgA). Diagnosed by clonal bone marrow plasma cells ≥ 10% (or plasmacytoma) plus CRAB end-organ criteria:

  • C alcium elevated ( hypercalcemia > 11 mg/dL)
  • R enal insufficiency (serum creatinine > 2.0 mg/dL due to Bence Jones light chain cast nephropathy)
  • A nemia (normocytic, Hgb < 10 g/dL)

B one lytic lesions ( punched-out lesions on skull/spine radiograph caused by osteoclast-activating factors IL-6 and RANKL)

Key Diagnostic Note : Monoclonal Gammopathy of Undetermined Significance ( MGUS ) features serum M-spike < 3 g/dL and marrow plasma cells < 10% WITHOUT CRAB symptoms . Waldenström Macroglobulinemia features IgM M-spike leading to hyperviscosity syndrome (retinal vein engorgement, headache, bleeding) without lytic bone lesions.